FMC Corp vs Progressive Corp — how do they compare? FMC Corp trades at $8.89 (market cap $1.41B), while Progressive Corp trades at $218.9 (market cap $126.95B). The key difference: Progressive Corp is far larger — about 90× FMC Corp's market cap, and FMC Corp pays the higher dividend (3.52%). Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Progressive Corp for 81 Days on average.
| FMC | PGR | |
|---|---|---|
Market Cap | $1.41B | $126.95B |
Volume | 4,507,459 | 2,749,438 |
Sector | Basic Materials | Financials |
52-Week High | $30.63 | $242.16 |
52-Week Low | $8.44 | $190.40 |
Typical Hold Time | 68 Days | 81 Days |
Enterprise Value | $5.22B | $135.16B |
Dividend Yield | 3.52% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
FMC trades at $8.92, down 1.22% on the day, with a bearish technical signal and negative profitability metrics including a net income margin of -84.83% and ROE of -91.47% for 2025. Recent news highlights regulatory progress with rimisoxafen in Brazil and a minority equity investment from Tessenderlo Group. Cash flow trends show volatility, with 2025 net cash flow positive at $227.20M but driven by financing activities as operating cash flow was negative.
The outlook is challenged by significant losses and high debt, though analyst consensus suggests upside with a $14.60 price target. Key risks include sustained negative margins, industry cyclicality, and execution of deleveraging plans. The stock presents a high-risk opportunity contingent on operational turnaround and debt reduction success.
Progressive Corporation (PGR) trades at $214.12, up 0.98% with a bullish technical outlook. The stock shows strong fundamentals with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income reaching $11.3B. Valuation metrics appear reasonable with P/E of 10.74 and ROE of 34.94%. Recent earnings beat expectations in Q2 2026, and analyst consensus targets $222.23.
PGR presents a compelling investment case with consistent revenue growth and strong profitability. However, investors face risks from intensifying auto insurance competition and potential margin pressure. The stock's current price near resistance levels suggests limited near-term upside despite positive analyst sentiment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →